$BLMH capitalizing on multi billion $ COVID-19 market Occupational health company Bloom Health Partners is really capitalizing on what has become a multi-billion dollar COVID-19 market.
$BLMH has made multiple agreements to supply testing for state-wide schools in the US and has also developed a large-scale facility in New Jersey to facilitate the high demand for testing in New York and the North-Eastern US.
On the business side of things, $BLMH.C recently gained DTC eligibility, equating to a larger investor pool and increased shareholder liquidity. Shares of the company also remained fairly stable this week, managing to stay above recent lows despite an overwhelmingly bearish market.
I’d really like to see some impressive earnings from $BLMH, as the company is currently operating at quite a high PB ratio. Hopefully, with the new testing facility and continued contracts for state testing, $BLMH will be able to deliver impressive metrics.
$BLMH is currently trading at $.32 and the company is valued at an MCAP of $12.46 million.
https://www.bloomhealthpartners.com/investors/#newsreleases